Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics
Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.
FDA brings lab tests under federal oversight in bid to improve accuracy and safety
WASHINGTON — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigoro...
Quest Diagnostics (DGX) Beats Q1 Earnings and Revenue Estimates
Quest Diagnostics (DGX) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $2.04 per share a year ago.
Quest Diagnostics raises 2024 profit and revenue forecast on strong demand
Laboratory operator Quest Diagnostic raised its 2024 profit and revenue forecast on Tuesday after beating first-quarter estimates on robust demand for its diagnostic tests.
Earnings Preview: Quest Diagnostics (DGX) Q1 Earnings Expected to Decline
Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quest Diagnostics (DGX) Collaborates With Broad Clinical Labs
Quest Diagnostics (DGX) collaboration is intended to demonstrate the clinical value of WGS as a first-line genetic test for postnatal diagnosis of developmental delay disorders.
Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024
SECAUCUS, N.J., March 19, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report first quarter 2024 financial re...
Quest Diagnostics' (DGX) New Pact to Reduce Food Insecurity
Quest Diagnostics' (DGX) recent collaboration aims to advance food access and healthy eating habits for underserved communities.
Quest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare Conference
SECAUCUS, N.J. , Feb. 23, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief ...
Quest Diagnostics (DGX) Boosts Oncology Portfolio With New Test
Quest Diagnostics (DGX) debuts the MelaNodal Predict test in collaboration with SkylineDx.
Quest Diagnostics (DGX) Debuts PFAS Blood Test Offering
Quest Diagnostics (DGX) introduces the first consumer-initiated blood test with physician consult on questhealth.com.
3 Medtech Stocks Likely to Top Estimates This Earnings Season
Here are three stocks, GMED, GKOS and PRCT, which are expected to beat earnings estimates in the ongoing reporting cycle.
Quest Diagnostics: Post-COVID Normalization Pretty Much Done
Quest Diagnostics is a leading provider of diagnostic information services, offering laboratory testing, genomics, and other diagnostic solutions. During 2020, COVID-19 detection tests played an im...
Quest Diagnostics Inc. (DGX) Q4 2023 Earnings Call Transcript
Quest Diagnostics Inc. (DGX) Q4 2023 Earnings Call Transcript
Related Companies